Nasdaq stocks posting largest percentage increases
AP - Fri Apr 24, 7:08PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
AGEN: 7.12 (+0.75), AMZN: 445.10 (+55.11), ACTG: 11.10 (+1.08), AFMD: 11.72 (+3.47), CNIT: 5.21 (+0.55), UCTT: 6.26 (+0.60)
Why Agenus Inc. Shares Are Soaring Today
Todd Campbell, The Motley Fool - Motley Fool - Fri Apr 24, 1:04PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares in Agenus shot higher by more...
AGEN: 7.12 (+0.75), INCY: 107.34 (-0.51), GSK: 46.59 (+0.28)
Agenus (AGEN) Strong On High Relative Volume Today
at The Street - Fri Apr 24, 9:03AM CDT
Trade-Ideas LLC identified Agenus (AGEN) as a strong on high relative volume candidate
AGEN: 7.12 (+0.75)
Agenus Inc's (AGEN) CEO Garo Armen on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Apr 24, 8:56AM CDT
AGEN: 7.12 (+0.75)
GSK's Malaria Vaccine Phase 3 Study Containing Agenus' QS-21 Published in The Lancet
Business Wire - Fri Apr 24, 6:00AM CDT
--EMA currently reviewing the regulatory application
AGEN: 7.12 (+0.75), GSK: 46.59 (+0.28)
Eli Lilly Beats on 1Q Earnings by Wide Margin, Affirms View - Analyst Blog
Arpita Dutt - Zacks Investment Research - Thu Apr 23, 9:50AM CDT
Eli Lilly's (LLY) first quarter earnings were better than expected despite the presence of generics and unfavorable currency movement.
AGEN: 7.12 (+0.75), BIIB: 401.71 (-28.57), AVEO: 1.92 (-0.08), LLY: 71.58 (-0.82)
Agenus reports Q1 results
Seeking Alpha - at Seeking Alpha - Thu Apr 23, 9:22AM CDT
AGEN: 7.12 (+0.75)
Agenus reports 1Q loss
Automated Insights - Thu Apr 23, 7:57AM CDT
NEW YORK (AP) _ Agenus Inc. (AGEN) on Thursday reported a loss of $18.8 million in its first quarter.
AGEN: 7.12 (+0.75)
Agenus (AGEN) Reports Wider-than-Expected Q1 Loss - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 23, 7:21AM CDT
Agenus (AGEN) Reports Wider-than-Expected Q1 Loss
AGEN: 7.12 (+0.75)
Agenus EPS of -$0.28
Seeking Alpha - at Seeking Alpha - Thu Apr 23, 6:30AM CDT
AGEN: 7.12 (+0.75)
Agenus Reports First Quarter 2015 Financial Results
Business Wire - Thu Apr 23, 6:00AM CDT
--Agenus to Host R&D Day in New York, NY on May 14
AGEN: 7.12 (+0.75)
Will Agenus (AGEN) Disappoint in Q1 Earning Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 1:30PM CDT
Agenus (AGEN) is expected to report first-quarter 2015 results on Apr 23.
AGEN: 7.12 (+0.75), BIIB: 401.71 (-28.57), INCY: 107.34 (-0.51), IMGN: 9.96 (-0.29)
Is Immuno-Oncology the Best Area of Biotech to Invest in Right Now?
George Budwell, The Motley Fool - Motley Fool - Wed Apr 22, 7:11AM CDT
Biotechnology is rapidly giving rise to ground-breaking new medicines that are dramatically changing the outlook for devastating diseases such as hepatitis C, malaria, and, perhaps most astoundingly, cancer. This innovation boom has gone hand in hand...
AGEN: 7.12 (+0.75), ADXS: 23.34 (-0.27), PFE: 35.27 (-0.09), MRK: 57.60 (+0.09), AZN: 71.79 (-1.34), BMY: 65.80 (-0.20), FPRX: 24.20 (-0.26)
Will Agenus (AGEN) Continue to Surge Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 6:28AM CDT
Will Agenus (AGEN) Continue to Surge Higher?
AGEN: 7.12 (+0.75)
Antigenics Up 75.6% Since SmarTrend Uptrend Call (AGEN)
Comtex SmarTrend(R) - Tue Apr 21, 9:47AM CDT
SmarTrend identified an Uptrend for Antigenics (NASDAQ:AGEN) on December 8th, 2014 at $3.30. In approximately 4 months, Antigenics has returned 75.65% as of today's recent price of $5.80.
AGEN: 7.12 (+0.75)
Agenus to Report First Quarter 2015 Financial Results on April 23, 2015; Conference Call to Follow
Business Wire - Mon Apr 20, 6:50AM CDT
Agenus Inc. (NASDAQ: AGEN) will release its first quarter 2015 financial results before the market opens on Thursday, April 23, 2015. Agenus executives will host a conference call at 11 a.m. Eastern Time the same day.
AGEN: 7.12 (+0.75)
3 Stocks That Could Double Your Money
George Budwell, The Motley Fool - Motley Fool - Sun Apr 19, 9:03AM CDT
If you're looking for a shot at doubling an investment, you'll want to take a look at the biotech industry. Biotech companies have been some of the best-performing stocks over the last couple of years thanks to the powerful confluence of numerous...
DVAX: 23.31 (-0.38), AGEN: 7.12 (+0.75), ACAD: 38.36 (-0.54)
Technical Coverage on Biotech Stocks -- Agenus, Raptor Pharma, KaloBios Pharma, Amicus Therapeutics, and Sarepta Therapeutics
PR Newswire - Fri Apr 17, 7:45AM CDT
Editor Note: For more information about this release, please scroll to bottom.
AGEN: 7.12 (+0.75), KBIO: 0.53 (-0.03), RPTP: 10.81 (+0.10), SRPT: 13.42 (-0.24), FOLD: 12.25 (-0.05)
Antigenics Shares Up 68.5% Since SmarTrend's Buy Recommendation (AGEN)
Comtex SmarTrend(R) - Tue Apr 14, 9:15AM CDT
SmarTrend identified an Uptrend for Antigenics (NASDAQ:AGEN) on December 8th, 2014 at $3.30. In approximately 4 months, Antigenics has returned 68.48% as of today's recent price of $5.56.
AGEN: 7.12 (+0.75)